These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2516854)

  • 1. Multiple myeloma: evidence that light chains play an immunoregulatory role in B-cell regulation.
    Ioannidis RA; Joshua DE; Warburton PT; Francis SE; Brown RD; Gibson J; Kronenberg H
    Hematol Pathol; 1989; 3(4):169-75. PubMed ID: 2516854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
    Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S
    Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human B cells secrete predominantly lambda L chains in the absence of H chain expression.
    Ambrosino DM; Kanchana MV; Delaney NR; Finberg RW
    J Immunol; 1991 Jan; 146(2):599-602. PubMed ID: 1898958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human myeloma cell line that does not express immunoglobulin but yields a high frequency of antibody-secreting hybridomas.
    Pickering JW; Gelder FB
    J Immunol; 1982 Jul; 129(1):406-12. PubMed ID: 6806365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
    Gallart T; Bladé J; Martínez-Quesada J; Sierra J; Rozman C; Vives J
    Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The surface expression of a tumor-associated antigen on human kappa myeloma cells.
    Boux HA; Raison RL; Walker KZ; Musgrove E; Basten A
    Eur J Immunol; 1984 Mar; 14(3):216-22. PubMed ID: 6423392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective induction of light chain synthesis in cultures of blood lymphocytes from patients with IgG myelomatosis.
    Walker LA; Johnson GD; MacLennan IC
    Clin Exp Immunol; 1988 Jan; 71(1):193-7. PubMed ID: 2832107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations affecting immunoglobulin light chain secretion by myeloma cells. I. Functional analysis by cell fusion.
    Mosmann TR; Baumal R; Williamson AR
    Eur J Immunol; 1979 Jul; 9(7):511-6. PubMed ID: 115698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring myeloma: light chain isotype suppression. A new parameter.
    Wearne A; Joshua DE; Kronenberg H
    Aust N Z J Med; 1985 Oct; 15(5):629-33. PubMed ID: 3937514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal kappa:lambda light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis.
    Low JM; Chauhan AK; Moore TL
    Scand J Immunol; 2007 Jan; 65(1):76-83. PubMed ID: 17212770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenylate cyclase-activating polypeptide is a potent inhibitor of the growth of light chain-secreting human multiple myeloma cells.
    Li M; Cortez S; Nakamachi T; Batuman V; Arimura A
    Cancer Res; 2006 Sep; 66(17):8796-803. PubMed ID: 16951196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies on human IgD. II. IgD-secreting cells preferentially elaborate IgD, lambda molecules.
    Litwin SD; Zehr BD
    Eur J Immunol; 1987 Apr; 17(4):491-5. PubMed ID: 3106066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro myotrophic effect of serum kappa chain immunoglobulins from a patient with kappa light chain myeloma and muscular hypertrophy.
    Delaporte C; Varet B; Fardeau M; Nochy D; Ract A
    J Clin Invest; 1986 Oct; 78(4):922-7. PubMed ID: 3093534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light chain isotype associated suppression of surface immunoglobulin expression on peripheral blood lymphocytes in myeloma during plateau phase.
    Wearne A; Joshua DE; Kronenberg H
    Br J Haematol; 1984 Nov; 58(3):483-9. PubMed ID: 6437432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-stimulated immunoglobulin production by chronic lymphocytic leukaemic lymphocytes.
    Johnstone AP; Jensenius JC; Millard RE; Hudson L
    Clin Exp Immunol; 1982 Mar; 47(3):697-705. PubMed ID: 6805990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The establishment of a human myeloma cell line elaborating lambda-light chain protein.
    Niho Y; Shibuya T; Yamasaki K; Kimura N
    Int J Cell Cloning; 1984 May; 2(3):161-72. PubMed ID: 6429256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic properties of human IgG Kappa and IgG lambda myeloma plasma cells.
    Hagner G
    Exp Hematol; 1983 Mar; 11(3):219-25. PubMed ID: 6403367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the human T cell lymphoma virus in B cell lines established from patients with adult T cell leukemia.
    Mann DL; Clark J; Clarke M; Reitz M; Popovic M; Franchini G; Trainor CD; Strong DM; Blattner WA; Gallo RC
    J Clin Invest; 1984 Jul; 74(1):56-62. PubMed ID: 6330177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human autoantibody silencing by immunoglobulin light chains.
    Wardemann H; Hammersen J; Nussenzweig MC
    J Exp Med; 2004 Jul; 200(2):191-9. PubMed ID: 15263026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of immunoglobulin heavy chain expression results in altered kappa/lambda light chain ratios.
    Holmberg D; Lundkvist I; Forni L; Ivars F; Coutinho A
    J Mol Cell Immunol; 1985; 2(1):51-6. PubMed ID: 3939751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.